Launching in summer 2023, the platform, dubbed Pulse by NABP, will help manufacturers, wholesalers, pharmacies and regulators “identify counterfeit or substandard prescription medications,” according to a July 27 news release from IBM.
The platform can also connect these entities with each other when required, and provide authorized partners that can help them “accurately trace prescription medications throughout the supply chain.”
The aim of the platform is to give patients more confidence that their prescriptions are legitimate, as well as combat the “gray market” companies in the industry, according to the release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.